Preparation method of glimepiride tablet

A technology for glimepiride and urea tablets, which is applied in the field of preparation of glimepiride tablets, can solve the problems that the dissolution rate is not easy to reach the quality standard, affects the production and marketing of glimepiride tablets, and cannot improve the properties of the dissolution rate, etc. Solve the effects of hydrophobicity and insolubility, easy decomposition at high temperature, increase disintegration and dissolution rate, and improve quality stability

Inactive Publication Date: 2009-01-14
上海天赐福生物工程有限公司
View PDF0 Cites 12 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

When the trial production is carried out according to the prescription process in the declared production data, the dissolution rate of the product in the quality inspection always fails to meet the requirements, which is only about 50% (the standard is: 75% of the labeled amount), which affects the specification. A major problem in the production and marketing of Limepiride Tablets
[0015] In addition, our research has found that glimepiride is soluble in chloroform, slightly soluble in ethanol or methanol, and almost insoluble in water or ether. It is a hydrophobic and insoluble substance and is easy to decompose at high temperature.
Therefore, there are two major problems in its preparations: 1) in the process of producing pharmaceutical preparations, the technical difficulty is relatively large, and its dissolution rate is difficult to reach the quality standard; It is difficult to meet the relevant regulations of the quality standard
[0016] By changing the glimepiride raw material from the 100-mesh fineness in the original process data to 200-mesh fineness, but the dissolution test result is 70% to 80%, which is still unstable; after adjusting the disintegrating agent and Treatment methods such as excipients cannot improve the dissolution profile

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of glimepiride tablet
  • Preparation method of glimepiride tablet

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] The preparation of embodiment 1 exceptionally beautiful urea tablet

[0034] (1) The raw material of glimepiride and micropowder silica gel are co-ground by micronization method, and passed through a 100 mesh sieve to obtain the mixed powder of micronized glimepiride and micropowder silica gel, wherein the weight ratio of glimepiride to micropowder silica gel 1:1;

[0035] (2) The mixed powder prepared in step (1), mannitol, calcium hydrogen phosphate, pregelatinized starch and starch filler, povidone binder, sodium carboxymethyl starch disintegrant, magnesium stearate lubrication Mix the ethanol solution with a volume concentration of 35% at room temperature for 15 minutes, pass through a 20-mesh sieve to granulate, dry the granules at 60°C, and then sieve the 20-mesh sieve for granulation. Check the content of the granules to determine the weight of the tablet. Meurea tablets.

[0036]Wherein, the amount of the mixed powder in the step (2): the glimepiride in the mi...

Embodiment 2

[0037] Example 2 Detection of Geweimeiurea Tablets

[0038] 1. Testing standard [National Drug Administration Standard (Trial) WS-102(X-087)-2001]

[0039] This product is especially meurea (C 24 h 34 N 4 o 5 S) should be 90.0% to 110.0% of the labeled amount.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a glimepinride tablet preparation method, which comprises 1) glimepinride and microposer silica gel are ground with a micronizaion method, and the mixture powder of micronized glimepinride and microposer silica gel is obtained after passing through a screen of 80 to 100 mesh; wherein, the weight ratio of the glimepinride and microposer silica gel is 1: 1; 2) the mixture powder obtained in the step 1) is mixed with filling agent, disintegrant, lubricant, bond and 30 percent to 40 percent by volume concentration of ethanol solution for 15 minutes to 20 minutes in normal temperature, and passes through a screen with 18 to 24 meshes to obtain the particles. The particles adopts micronization technique to increase the surface area of slightly soluble main drug to facilitate glimepinride pulverization so that the wettability of the surface of the powder particles is improved and the dissolution of the raw medicine in tablets and the quality stability of the product during storage time are improved.

Description

technical field [0001] The invention belongs to the field of glimepiride tablets, in particular to a preparation method of glimepiride tablets. Background technique [0002] Glimepiride Tablet, the structural formula is It is a sulfonylurea hypoglycemic drug, which was successfully developed by the German Hoechst AG pharmaceutical company in the 1980s as a treatment for type II diabetes. As a new generation of sulfonylurea hypoglycemic drugs after tolbutamide (D860) and glibenclamide (glibenclamide), it has the characteristics of high efficiency, long-acting, small dose, and low side effects. It has been approved for marketing in Germany, Sweden, Denmark, Switzerland and other countries, and was approved for marketing by the US FDA in 1995. It has been widely used in the treatment of type II diabetes in Europe and the United States. [0003] As a new type of sulfonylurea hypoglycemic drug, glimepiride has a different action site from traditional sulfonylurea drugs, mainl...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/20A61K31/64A61K47/04A61P3/10
Inventor 陆裕德杨瑞群黄星
Owner 上海天赐福生物工程有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap